National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Kaposi Sarcoma Treatment (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 04/28/2008



General Information About Kaposi Sarcoma






Classic Kaposi Sarcoma






African Kaposi Sarcoma






Immunosuppressive Treatment-related Kaposi Sarcoma






Epidemic Kaposi Sarcoma






Nonepidemic Gay-related Kaposi Sarcoma






Recurrent Kaposi Sarcoma






Treatment Option Overview






Treatment Options for Kaposi Sarcoma






To Learn More About Kaposi Sarcoma






Get More Information From NCI






Changes to This Summary (04/28/2008)






About PDQ



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
The Nation's Investment in Cancer Research FY 2010

Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Nonepidemic Gay-related Kaposi Sarcoma

There is a type of nonepidemic Kaposi sarcoma that develops in homosexual men who have no signs or symptoms of HIV infection. This type of Kaposi sarcoma progresses slowly, with new lesions appearing every few years. The lesions are most common on the arms, legs, and genitals, but can develop anywhere on the skin.

This type of Kaposi sarcoma is rare and treatment information is not included in this summary.

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov